In patients on dialysis, the use of an injectable monoclonal antibody for prevention of osteoporosis-related fractures may increase the risk of MACE compared with oral bisphosphonates, observational ...

Some say a new treatment for the bone-weakening disease is a breakthrough. May 2, 2007 — -- A new option in the treatment of osteoporosis could one day change the way many of the 10 million ...

GAITHERSBURG, Maryland (Reuters) - Amgen Inc pledged on Thursday to closely monitor the long-term safety of its novel osteoporosis injection as U.S. advisers weighed the future of the company's most ...

The primary cause of osteoporosis is a change in the bone’s structure. Osteoporosis is a bone disease that occurs when your bone mass decreases, leading to an increased risk of fractures, or broken ...